Medicare Enrolled
Dr. Daniel Linn, MD
Urology Physician · Monroe, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Linn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Linn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Linn
Dr. Daniel Linn is an urology physician in Monroe, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Linn performed 1,428 Medicare services across 1,160 unique beneficiaries.
Between the years covered by Open Payments, Dr. Linn received a total of $10,871 from 61 pharmaceutical and/or device companies across 511 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Linn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 47% volume in NC
$10,871 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,428
Medicare services
Top 47% in NC for urology physician
1,160
Unique beneficiaries
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~75 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
367 | $93 | $158 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
208 | $4 | $17 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
125 | $167 | $585 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
105 | $117 | $263 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
91 | $58 | $111 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
77 | $8 | $45 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
72 | $103 | $295 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
41 | $72 | $185 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
40 | $660 | $1,850 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
39 | $19 | $264 |
| Injection, garamycin, gentamicin, up to 80 mg | 39 | $2 | $7 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
27 | $174 | $626 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
24 | $3 | $17 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
23 | $306 | $1,850 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
22 | $7 | $220 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
18 | $153 | $677 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
17 | $238 | $826 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
17 | $2 | $15 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
15 | $92 | $1,493 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
14 | $429 | $2,134 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
12 | $953 | $2,500 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
12 | $559 | $2,215 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $117 | $231 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
11 | $153 | $1,295 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.9% high complexity
17.8% medium
78.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,871
Total received (2018-2024)
Avg $1,553/year across 7 years
Top 17% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
511
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,582 (97.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$289 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,916
2023
$2,147
2022
$2,063
2021
$1,276
2020
$970
2019
$1,223
2018
$1,275
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$202
Endo USA, Inc.
$185
UROGEN PHARMA, INC.
$171
Dendreon Pharmaceuticals LLC
$160
Laborie Medical Technologies Corp.
$156
Sumitomo Pharma America, Inc.
$152
Boston Scientific Corporation
$137
Olympus America Inc.
$129
Myriad Genetic Laboratories, Inc.
$121
PROGENICS PHARMACEUTICALS, INC.
$96
PFIZER INC.
$87
COLOPLAST CORP
$64
Ferring Pharmaceuticals Inc.
$48
Endo Pharmaceuticals Inc.
$46
ABBVIE INC.
$43
Blue Earth Diagnostics Limited
$32
Teleflex LLC
$26
Ambu Inc.
$22
Janssen Biotech, Inc.
$22
Smith+Nephew, Inc.
$19
Top 3 companies account for 29.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,637
PFIZER INC.
$709
Sumitomo Pharma America, Inc.
$603
Endo Pharmaceuticals Inc.
$579
NeoTract Inc.
$578
Dendreon Pharmaceuticals LLC
$556
Medtronic, Inc.
$520
Teleflex LLC
$518
Coloplast Corp
$511
Boston Scientific Corporation
$408
Antares Pharma, Inc.
$395
Laborie Medical Technologies Corp.
$317
Myovant Sciences Inc.
$251
UROGEN PHARMA, INC.
$190
Endo USA, Inc.
$185
AMAG Pharmaceuticals, Inc.
$162
UroGen Pharma, Inc.
$159
UROVANT SCIENCES INC
$154
TOLMAR Pharmaceuticals, Inc.
$154
Janssen Biotech, Inc.
$146
BOSTON SCIENTIFIC CORPORATION
$134
Olympus America Inc.
$129
Avadel Specialty Pharmaceuticals, LLC
$129
PROCEPT BioRobotics Corporation
$128
Myriad Genetic Laboratories, Inc.
$121
ConvaTec Inc.
$118
ABBVIE INC.
$106
COLOPLAST CORP
$96
PROGENICS PHARMACEUTICALS, INC.
$96
AbbVie, Inc.
$78
C. R. Bard, Inc. & Subsidiaries
$76
Progenics Pharmaceuticals, Inc.
$60
Axonics, Inc.
$60
Rochester Medical Corporation
$58
Smith+Nephew, Inc.
$55
Blue Earth Diagnostics Limited
$52
Travere Therapeutics, Inc.
$50
Tolmar, Inc.
$50
Merck Sharp & Dohme LLC
$48
Ferring Pharmaceuticals Inc.
$48
Bayer HealthCare Pharmaceuticals Inc.
$44
Zyla Life Sciences, Inc.
$41
Merck Sharp & Dohme Corporation
$40
Hollister Incorporated
$31
Zyla Life Sciences
$28
Medtronic USA, Inc.
$27
Acerus Pharmaceuticals Corporation
$25
Ambu Inc.
$22
AbbVie Inc.
$22
ACCORD HEALTHCARE, INC.
$22
Clarus Therapeutics Inc.
$21
Cook Medical LLC
$16
Axonics Modulation Technologies, Inc.
$16
ABC Home Medical Supply, Inc.
$16
DENTSPLY IH Inc.
$15
Retrophin, Inc.
$13
AXOGEN
$12
Allergan, Inc.
$11
Mission Pharmacal Company
$11
NxThera, Inc.
$9
Intuitive Surgical, Inc.
$6
Top 3 companies account for 27.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ADVANCE · AMS · AMS 700 · AQUABEAM ROBOTIC SYSTEM · AVEED · AdVance XP · Androgel · AxoGuard Nerve Protector · Axonics · Axonics r-SNM System · BOTOX · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CONTINENCE CARE · COOK MEDICAL LASERS · Da Vinci Surgical System · EDEX · ELIGARD · ERLEADA · Erleada · FEMALE INCONTINENCE · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL - THERAPIES · GENTLECATH · INTERSTIM · INTRAROSA · Infyna Chic · JATENZO · JELMYTO · KEYTRUDA · LITHOCLAST · LITHOVUE · LUPRON DEPOT · LoFric · Luja Coude · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · PELVIC FLOOR REPAIR · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PVC · PYLARIFY · Porges Coloplast · RESTORELLE · REZUM · Rezum · Rezum Generator · SPEEDICATH · SPRIX · STRAVIX · STRAVIX PL · SWISS LITHOCLAST TRILOGY · SpeediCath · TACTRA · TITAN · TOVIAZ · TRIA · Thiola · Titan · Tria Firm · UROLIFT · Uribel · UroLift · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZORVOLEX · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
20
Per 100K population
8.2
County median income
$99,243
Nearest hospital
ATRIUM HEALTH UNION
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Linn is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of NC peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Linn experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Linn performed 367 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Linn receive payments from pharmaceutical companies?
Yes. Dr. Linn received a total of $10,871 from 61 companies across 511 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Linn's costs compare to other urology physicians in Monroe?
Dr. Linn's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Linn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Monroe
Browse urology physicians in Monroe ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology